Climb Blog

ClimbData IntegrationPharmacokinetics and PharmacodynamicsRegulatory ComplianceRegulatory SubmissionRegulatory SubmissionsResearch CollaborationSENDStudy ManagementToxicologyWorkflow Automation

Generating SEND from Climb™

Instem Team

Non-GLP studies that support regulatory safety decisions are required by the FDA to be submitted in SEND, regardless of GLP status. Data collected in Climb™ can be efficiently converted into submission-ready SEND using Instem’s Submit™...

ClimbStudy Management

The 3Rs of Humane Animal Research

Instem Team

In vivo research is essential for new therapeutics, but minimizing animal burden is key. Instem’s Climb software helps ensure ethical research by supporting the principles of Reduction, Refinement, and Replacement.

ClimbData IntegrationPharmacokinetics and PharmacodynamicsPharmacologyResearch CollaborationStudy ManagementStudy Planning and ExecutionToxicologyWorkflow Automation

Climb Release 20251217.1 – What’s New?

Instem Team

Deployed on: December 17, 2025

We’re excited to share the latest updates in Climb! This release brings powerful enhancements across Studies, Workflow, Animals, Orders, API & Webhooks, and more—plus important fixes to improve your experience.

Stay up to Date

Get expert tips, industry news, and fresh content delivered to your inbox.